[1] |
孔娇, 陈园园, 蔡青山, 等. 宏基因二代测序技术对非结核分枝杆菌肺病的诊断价值. 中国防痨杂志, 2022, 44(11): 1135-1140. doi:10.19982/j.issn.1000-6621.20220298.
|
[2] |
van Ingen J, Boeree MJ, van Soolingen D, et al. Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?. Infect Genet Evol, 2012, 12(4): 832-837. doi:10.1016/j.meegid.2011.10.006.
|
[3] |
Cowman S, van Ingen J, Griffith DE, et al. Non-tuberculous mycobacterial pulmonary disease. Eur Respir J, 2019, 54(1):1900250. doi:10.1183/13993003.00250-2019.
|
[4] |
金向红, 黄向韵, 陈鲜宝, 等. 宏基因靶向三代测序在下呼吸道感染病原体检测的诊断效能和临床价值. 浙江临床医学, 2024, 26(6): 807-809, 813.
|
[5] |
陶锋, 李一荣, 周艳梅, 等. 靶向宏基因组测序技术在不明原因肺部感染病原学诊断中的价值. 中国病原生物学杂志, 2024, 19(11): 1290-1294. doi:10.13350/j.cjpb.241108.
|
[6] |
刘盛盛, 唐神结. 《非结核分枝杆菌病诊断与治疗指南(2020年版)》解读. 结核与肺部疾病杂志, 2021, 2(2): 108-115. doi:10.3969/j.issn.2096-8493.2021.02.004.
|
[7] |
中国疾病预防控制中心. 中国结核病防治规划:痰涂片镜检质量保证手册. 北京: 中国协和医科大学出版社, 2004.
|
[8] |
赵雁林, 刘志敏. 结核病实验室标准化操作与网络建设. 北京: 人民卫生出版社, 2013.
|
[9] |
Gopalaswamy R, Shanmugam S, Mondal R, et al. Of tuberculosis and non-tuberculous mycobacterial infections-a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci, 2020, 27(1): 74. doi:10.1186/s12929-020-00667-6.
|
[10] |
Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet, 2013, 381(9877): 1551-1560. doi:10.1016/S0140-6736(13)60632-7.
|
[11] |
秦中华, 景晔, 杜岩青, 等. 339株非结核分枝杆菌临床分离株菌种鉴定及耐药性分析. 中国防痨杂志, 2020, 42(6): 630-633. doi:10.3969/j.issn.1000-6621.2020.06.017.
|
[12] |
李爱芳, 谈小文, 崔晓利, 等. 荧光PCR熔解曲线法在非结核分枝杆菌菌种鉴定中的应用价值. 中国防痨杂志, 2021, 43(7): 664-669. doi:10.3969/j.issn.1000-6621.2021.07.005.
|
[13] |
刘珑玲, 陈世玖. 非结核分枝杆菌感染的分子生物学快速诊断技术. 中华医学杂志, 2014, 94(38): 3039-3040. doi:10.3760/cma.j.issn.0376-2491.2014.38.022.
|
[14] |
周秋菊, 於青峰, 杨阳, 等. 非结核分枝杆菌临床分离株的流行病学及临床特征分析. 中国现代医生, 2020, 58(31): 125-129.
|
[15] |
Wang Y, Zhao Y, Bollas A, et al. Nanopore sequencing technology, bioinformatics and applications. Nat Biotechnol, 2021, 39(11): 1348-1365. doi:10.1038/s41587-021-01108-x.
pmid: 34750572
|
[16] |
Petersen LM, Martin IW, Moschetti WE, et al. Third-Genera-tion Sequencing in the Clinical Laboratory: Exploring the Advantages and Challenges of Nanopore Sequencing. J Clin Microbiol, 2019, 58(1): e01315-19. doi:10.1128/JCM.01315-19.
|
[17] |
Wei W, Cao J, Wu XC, et al. Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice. Infection, 2023, 51(2): 397-405. doi:10.1007/s15010-022-01890-z.
|
[18] |
缪青, 姚雨濛, 潘珏, 等. 宏基因二代测序技术对非结核分枝杆菌感染病原学诊断的价值. 中国临床医学, 2020, 27(4): 559-562. doi:10.12025/j.issn.1008-6358.2020.20201289.
|